13F Filings History of BIOTECH GROWTH N V

Latest 13F filing
Q1 2026 - 15 May 2026
13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • BIOTECH GROWTH N V Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • <a href="/investor/0001674546-bellevue-group-ag">Bellevue Group AG</a> is reporting for BIOTECH GROWTH N V.
Manager Names, identifiers, and filing context for this profile. 1 identity field
Manager location
Willemstad, Netherlands Antilles

Follow Filing Activity

Follow BIOTECH GROWTH N V with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Bellevue Group AG is reporting for BIOTECH GROWTH N V:

Name Holdings Value Location File Number
Bellevue Group AG $4,201,990,189 Zurich 028-17462
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .